SAN DIEGO, Calif. – The Advanced Lateral Flow Conference (ALFC) is proud to announce the winners of its 2024 awards, recognizing outstanding achievements and contributions in the lateral flow diagnostics industry. The awards were presented during the conference held February 13–14, 2024, at the Hard Rock Hotel in San Diego, Calif.
Innovation Award
The Innovation Award recognizes developers, creators, or direct facilitators of groundbreaking products and novel technologies that push the boundaries of the industry. Finalists pitch their innovations at ALFC, with the audience selecting the winner.
- Winner: LFAnt, for the Compact, the world’s first handheld and portable magnetic lateral flow reader platform for quantitative testing from point of care to anywhere.
Lifetime Achievement Award
The Lifetime Achievement Award honors individuals or organizations who have dedicated their careers to advancing lateral flow diagnostics and made significant contributions over a sustained period.
- Winner: Dr. Thomas Tisone, BioDot cofounder, for his visionary entrepreneurship and substantial contributions to lab automation.
Leadership in Diagnostics Award
The Leadership in Diagnostics Award highlights individuals or organizations demonstrating outstanding leadership, collaboration, and strategic vision in driving the growth of the lateral flow diagnostics industry.
- Winner: Ted Meigs, Kinematic Automation (part of Ascential Medical & Lifesciences), whose extensive experience in automation and design has influenced the LFA industry significantly.
Poster Awards
The ALFC Poster Awards recognize the most innovative and impactful research presented during the ALFC 2024 poster sessions. These awards are determined by a panel of ALFC judges.
- Winner (tie): Dr. Nicolas Heureux’s team at Kimialys; and John Kelly, the founder and CEO of Atomo Diagnostics.
DCN Dx congratulates all the winners and acknowledges their vital contributions to the field of lateral flow diagnostics. To learn more about ALFC and its awards, visit ALFC2024.com.
About the Advanced Lateral Flow Conference
The Advanced Lateral Flow Conference (ALFC), presented by DCN Dx, is the leading global event for lateral flow diagnostic developers, manufacturers, and those driving their commercial success. This annual conference delivers cutting-edge insights through expert-led sessions and provides a platform for researchers and developers to exchange ideas and innovations. Attendees gain practical insights to advance their businesses, deepen their knowledge of rapid diagnostics, and connect with leading minds shaping the future of point-of-care testing. To learn more about ALFC, visit alfc2025.com.
About DCN Dx
DCN Dx, based in Carlsbad, California, specializes in lateral flow diagnostics development and manufacturing, and IVD regulatory consulting and clinical research. DCN Dx’s multidisciplinary CDMO specializes in creating tailored assay systems, consumables, and instruments for point-of-use applications, with a particular expertise in lateral flow assays. Their clinical research services group specializes in the planning, execution, and oversight of IVD clinical trials, inclusive of clinical operations, data management, and biostatistics, and regulatory services.
DCN Dx’s personalized approach to IVD product development and clinical trials has supported hundreds of programs and clients. They can oversee every stage from concept to assay development and platform integration, through clinical trials to manufacturing or only handle the aspects you request. In addition to lateral flow assays, DCN Dx’s clinical research expertise extends to any in vitro diagnostic, all with a focus on innovation, usability, and performance.
With a commitment to quality, customer satisfaction, and industry-leading expertise, DCN Dx is setting the benchmark for excellence in IVD services. To learn more about how we can support your diagnostic needs, visit dcndx.com.
